Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Doxycycline for Norplant-induced Bleeding
NCT00064766Phase 4Unknown
- Sponsor
- Eunice Kennedy Shriver National Institute of Child Health and Human Development
- Start
- Feb 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in breakthrough bleeding comparing Doxycycline with Placebo (2 arms). Primary endpoint: Occurrence of Uterine Bleeding and Spotting at 6 months. Status: unknown.
02
Drugs
doxycycline
03
Conditions
breakthrough bleeding
Beyond the preview
Go deeper on NCT00064766.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00064766.